Profile data is unavailable for this security.
About the company
Ascendis Health Limited is a South Africa-based health and wellness investment holding company. The Company mainly focuses on supplying pharmaceutical and animal health products, as well as clinical and diagnostic medical devices. The Company operates through four segments: Consumer Health, Pharma, Medical Devices, and Animal Health. Its Consumer Health segment is focused on skin and body, over the counter, complementary, and alternative consumer products. Its Pharma segment incorporates Ascendi's pharmaceutical products. Its Medical Devices incorporates the supply of medical devices and consumables. Its Animal Health incorporates manufacturing and distribution of animal health products. Its brands include Bettaway, Chela-Fer, Mg Chela Mag, Cheg-Preg, JungleVites, MenaCal7, Solal, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, The Scientific Group, Pharmachem and Vitaforce.
- Revenue in ZAR (TTM)1.50bn
- Net income in ZAR-50.51m
- Incorporated2008
- Employees3.20k
- LocationAscendis Health Ltd1 Carey Street, WynbergSANDTON 2090South AfricaZAF
- Phone+27 110369600
- Fax+27 110369602
- Websitehttps://ascendishealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purple Biotech Ltd | 0.00 | -367.16m | 259.90m | 20.00 | -- | 0.3956 | -- | -- | -0.3156 | -0.3156 | 0.00 | 0.5048 | 0.00 | -- | -- | 0.00 | -40.39 | -37.24 | -47.34 | -41.28 | -- | -- | -- | -9,415.70 | -- | -- | 0.0101 | -- | -- | -- | 8.25 | -- | -28.45 | -- |
| Matricelf Ltd | 0.00 | -68.59m | 343.58m | -- | -- | 2.58 | -- | -- | -0.8777 | -0.8777 | 0.00 | 1.67 | 0.00 | -- | -- | -- | -39.69 | -- | -42.80 | -- | -- | -- | -- | -- | -- | -- | 0.0527 | -- | -- | -- | -10.77 | -- | -- | -- |
| Ascendis Health Ltd | 1.50bn | -50.51m | 512.30m | 3.20k | -- | 0.7991 | 13.55 | 0.3425 | -0.0538 | -0.0293 | 2.18 | 1.01 | 1.19 | 2.14 | 4.73 | -- | -4.01 | -13.64 | -6.56 | -30.61 | 39.75 | 41.43 | -3.38 | -46.46 | 0.9469 | -- | 0.116 | -- | -1.54 | -22.55 | 62.29 | -- | -30.14 | -- |
| DNA Group TR Ltd | 1.52m | -5.84m | 572.29m | 14.00 | -- | 1.46 | -- | 377.14 | -0.0088 | -0.0088 | 0.0025 | 0.6429 | 0.0038 | -- | 1.37 | 21,857.14 | -1.45 | -23.54 | -1.46 | -26.27 | -- | -- | -384.64 | -7,406.24 | -- | -- | 0.00 | -- | -45.36 | -- | 95.00 | -- | -- | -- |
| GFC Green Fields Capital Ltd | 0.00 | 77.83m | 612.79m | 2.00 | 7.90 | 0.7807 | 7.87 | -- | 1.56 | 1.56 | 0.00 | 15.77 | 0.00 | -- | -- | -- | 3.26 | 1.99 | 10.38 | 3.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 844.90 | 45.32 | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Excelsia Capital Pty Ltd.as of 31 Dec 2022 | 264.55k | 0.04% |
| Old Mutual Customised Solutions (Pty) Ltd.as of 31 Dec 2022 | 27.49k | 0.00% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 3.15k | 0.00% |
| Ashburton Fund Managers (Pty) Ltd.as of 31 Mar 2019 | 169.00 | 0.00% |
| Corion Capital (Pty) Ltd.as of 31 Dec 2022 | 0.00 | 0.00% |
